No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study

Authors Dominguez-Valentin M, Plazzer JP, et al.
Citation J Clin Med. 2021 Jun 28;10(13):2856.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/34203177/
PMCID PMC8269121

Read this next

Height and Colorectal and Endometrial Cancer Risk for Persons with Lynch Syndrome